| Literature DB >> 31387573 |
Saba Kassim1, Badr Othman2, Sakher AlQahtani3, Alemad Mustafa Kawthar4, Sterling M McPherson5, Barbara L Greenberg6.
Abstract
BACKGROUND: Screening for medical conditions (MCs) of public health importance is a first step in disease prevention and control. Prior studies in the United States found oral health care providers (OHCPS) embrace screening for increased risk of medical conditions in the dental setting. Our objectives were to assess Saudi Arabian (SA) dentist's attitudes, willingness and perceived barriers towards implementing screening for MCs into their dental practices.Entities:
Keywords: Attitudes; Dentists; Medical screening; Saudi Arabia Oral health
Mesh:
Year: 2019 PMID: 31387573 PMCID: PMC6685149 DOI: 10.1186/s12903-019-0870-x
Source DB: PubMed Journal: BMC Oral Health ISSN: 1472-6831 Impact factor: 2.757
Sociodemographic characteristics of respondents (n = 143)
| Variable | Frequency (%), or Mean ± SD |
|---|---|
| Age | 30.96 ± 5.28 |
| Nationality | |
| Saudi | 90 (62.9) |
| Non Saudi | 53 (37.1) |
| Specialty | |
| General practitioner dentist | 64 (44.8) |
| Prosthodontist | 20 (14.0) |
| Endodontist | 14 (9.8) |
| Oral and Maxillofacial | 10 (7.0) |
| Pediatric dentistry | 14 (9.8) |
| Periodontist | 9 (6.3) |
| Other (e.g. dental public health) | 12 (8.4) |
| In practice | |
| ≤10 years | 101 (70.9) |
| >10 years | 42 (29.1) |
| Locality | |
| Urban | 130 (91.2) |
| Suburban | 13 (8.8) |
Fig. 1Respondents’ attitudes towards the important of identifying patients who may benefit from interventions to prevent or control the onset of MCs, (n = 143)
Distribution of responses (frequency and percentages), mean rank and pairwise comparisons for Question 1–4, (n = 143)
| 1.1.How important do you think it is for a dentist to perform/conduct chairside screening for each of the following? | Very important (1) N (%) | Somewhat important (2) N (%) | Not sure (3) N (%) | Somewhat unimportant (4) N (%) | Very Unimportant (5) N (%) | Total | Median (IQR)† | Mean + rank | Pairwise comparisons | |||||
| a | b | C | d | e | ||||||||||
| (a) Cardiovascular diseases | 116 (81.1) | 25(17.5) | 1 (0.7) | 1 (0.7) | 0 (0.0) | 143 | 1(0) | 2.92 | a | |||||
| (b) Hypertension | 97 (67.8) | 43 (30.1) | 3 (2.1) | 0 (0.0) | 0 (0.0) | 143 | 1(1) | 3.24 | b | |||||
| (c) Diabetes mellitus | 113 (79) | 27(18.9) | 3 (2.1) | 0 (0.0) | 0 (0.0) | 143 | 1(0) | 2.98 | c | |||||
| (d) HIV | 112 (78.3) | 28 (19.6) | 2 (1.4) | 0 (0.0) | 1 (0.7) | 143 | 1(0) | 3.00 | d | |||||
| (e) Hepatitis | 121 (84.6) | 20 (14.0) | 1 (0.7) | 0 (0.0) | 1 (0.7) | 143 | 1(0) | 2.85 | e | |||||
| Friedman test significant difference between the mean ranks | ||||||||||||||
| 2.If you were considering incorporating medical screening into your practice, how willing would you be to do each of the following? | Very willing (1) N (%) | Somewhat willing (2) N (%) | Not sure (3) N (%) | Somewhat unwilling (4) N (%) | Very unwilling (5) N (%) | Total | Median (IQR))† | Mean + rank | Pairwise comparisons | |||||
| a | b | c | d | |||||||||||
| (a) Conduct chairside screening that yields immediate results | 89 (62.2) | 43 (30.1) | 9 (6.3) | 1 (0.7) | 1 (0.7) | 143 | 1(1) | 2.50 | a | |||||
| (b) Conduct chairside screening that requires sending samples to an outside laboratory | 68 (47.6) | 55 (38.5) | 16 (11.2) | 3 (2.1) | 1 (0.7) | 143 | 2(1) | 2.81 | b | * | ||||
| (c) Discuss screening results with patients immediately following screening | 90 (62.9) | 44 (30.8) | 7 (4.9) | 2 (1.4) | 0 (0.0) | 143 | 1(1) | 2.45 | c | |||||
| (d) Refer a patient for consultation with a physician | 106 (74.1) | 34 (23.8) | 1 (0.7) | 1 (0.7) | 1 (0.7) | 143 | 1(1) | 2.23 | d | * | ||||
| Friedman test significant difference between the mean ranks | ||||||||||||||
| 3. How willing would you be to gather the following samples or data as part of your practice? | Very willing (1) N (%) | Somewhat willing (2) N (%) | Not sure (3) N (%) | Somewhat unwilling (4) N (%) | Very unwilling (5) N (%) | Total | Median (IQR))† | Mean + rank | Pairwise comparisons | |||||
| a | b | c | d | |||||||||||
| (a) Oral fluids for salivary diagnostics | 33 (23.1) | 34 (23.8) | 49 (34.3) | 19 (13.3) | 8 (5.6) | 143 | 3(1) | 2.75 | a | * | ||||
| (b) Drop of blood by finger stick | 45 (31.5) | 33 (23.1) | 36 (25.2) | 22 (15.4) | 7 (4.9) | 143 | 2(2) | 2.58 | b | |||||
| (c) Blood pressure measurements | 56 (39.2) | 40 (28.0) | 26 (18.2) | 14 (9.8) | 7 (4.9) | 143 | 2(2) | 2.22 | c | * | ||||
| (d) Height and weight (BMI) | 49 (34.3) | 42 (29.4) | 24 (16.8) | 14 (9.8) | 14 (9.8) | 143 | 2(2) | 2.45 | d | |||||
| Friedman test significant difference between the mean ranks | ||||||||||||||
| 4. If you were considering incorporating medical screening into your practice, how important would each of the following issues be? | Very important (1) N (%) | Somewhat important (2) N (%) | Not sure (3) N (%) | Somewhat unimportant (4) N (%) | Very Unimportant (5) N (%) | Total | Median (IQR)† | Mean + rank | Pairwise comparisons | |||||
| a | b | c | d | e | ||||||||||
| (a) Time | 110 (76.9) | 33 (23.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 143 | 1(0) | 2.63 | a | * | ||||
| (b) Cost | 89 (62.2) | 51 (35.7) | 2 (1.4) | 1 (0.7) | 0 (0.0) | 143 | 1(1) | 3.00 | b | * | ||||
| (c) Insurance coverage | 66 (46.2) | 48 (33.6) | 20 (14.0) | 7 (4.9) | 2 (1.4) | 143 | 2(1) | 3.56 | c | * | * | * | * | |
| (d) Patient willingness | 100 (69.9) | 39 (27.3) | 3 (2.1) | 1 (0.7) | 0 (0.0) | 143 | 1(1) | 2.79 | d | * | ||||
| (e) Liability | 90 (62.9) | 44 (30.8) | 7 (4.9) | 2 (1.4) | 0 (0.0) | 143 | 1(1) | 3.02 | e | * | ||||
Friedman test significant difference between the mean ranks χ2 (4) = 54.24, p < 0.001; *significantly different at P < 0.05
+ Lower mean rank indicates more important/ more willing; Median (IQR) = Median with interquartile range